Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Standardized Disease Management on Exacerbation of COPD in Primary Health Care in China: a Multicenter, Adjudicator-Blinded, Parallel, Cluster Randomized Clinical Trial

NCT04664491 is registered in ClinicalTrials.gov with China-Japan Friendship Hospital as lead sponsor.

NCT NCT04664491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04664491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Standardized Disease Management on Exacerbation of COPD in Primary Health Care in China: a Multicenter, Adjudicator-Blinded, Parallel, Cluster Randomized Clinical Trial
Lead sponsor
China-Japan Friendship Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 4, 2023
Completion date
April 1, 2027
Enrollment
3,456 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease